135 related articles for article (PubMed ID: 38141320)
1. Posterior cerebral artery involvement in unilateral moyamoya disease is exclusively ipsilateral and influenced by RNF213 mutation gene dose: The SUPRA Japan study: PCA involvement in unilateral moyamoya.
Mineharu Y; Takagi Y; Koizumi A; Morimoto T; Funaki T; Hishikawa T; Araki Y; Hasegawa H; Takahashi JC; Kuroda S; Houkin K; Miyamoto S;
J Stroke Cerebrovasc Dis; 2024 Feb; 33(2):107513. PubMed ID: 38141320
[TBL] [Abstract][Full Text] [Related]
2. RNF213 as the major susceptibility gene for Chinese patients with moyamoya disease and its clinical relevance.
Zhang Q; Liu Y; Zhang D; Wang R; Zhang Y; Wang S; Yu L; Lu C; Liu F; Zhou J; Zhang X; Zhao J
J Neurosurg; 2017 Apr; 126(4):1106-1113. PubMed ID: 27128593
[TBL] [Abstract][Full Text] [Related]
3. Importance of RNF213 polymorphism on clinical features and long-term outcome in moyamoya disease.
Kim EH; Yum MS; Ra YS; Park JB; Ahn JS; Kim GH; Goo HW; Ko TS; Yoo HW
J Neurosurg; 2016 May; 124(5):1221-7. PubMed ID: 26430847
[TBL] [Abstract][Full Text] [Related]
4.
Ok T; Jung YH; Kim J; Park SK; Park G; Lee S; Lee KY
J Am Heart Assoc; 2022 Aug; 11(15):e025676. PubMed ID: 35876407
[TBL] [Abstract][Full Text] [Related]
5. Predictive role of heterozygous p.R4810K of
Wang Y; Zhang Z; Wei L; Zhang Q; Zou Z; Yang L; Li D; Shang M; Han C; Mambiya M; Bao X; Li Q; Hao F; Zhang K; Wang H; Liu S; Liu M; Zeng F; Nie F; Wang K; Liu W; Duan L
Neurology; 2020 Feb; 94(7):e678-e686. PubMed ID: 31949090
[TBL] [Abstract][Full Text] [Related]
6. Rare variants of RNF213 and moyamoya/non-moyamoya intracranial artery stenosis/occlusion disease risk: a meta-analysis and systematic review.
Liao X; Deng J; Dai W; Zhang T; Yan J
Environ Health Prev Med; 2017 Nov; 22(1):75. PubMed ID: 29165161
[TBL] [Abstract][Full Text] [Related]
7. Development of atherosclerotic-moyamoya syndrome with genetic variant of RNF213 p.R4810K and p.T1727M: A case report.
Liu Y; Wu X; Fan Z; Cheng J; Zhong L; Lin Y; Qu X
Clin Neurol Neurosurg; 2018 May; 168():163-166. PubMed ID: 29567577
[TBL] [Abstract][Full Text] [Related]
8. Molecular analysis of RNF213 gene for moyamoya disease in the Chinese Han population.
Wu Z; Jiang H; Zhang L; Xu X; Zhang X; Kang Z; Song D; Zhang J; Guan M; Gu Y
PLoS One; 2012; 7(10):e48179. PubMed ID: 23110205
[TBL] [Abstract][Full Text] [Related]
9. RNF213 p.R4810K Polymorphism and the Risk of Moyamoya Disease, Intracranial Major Artery Stenosis/Occlusion, and Quasi-Moyamoya Disease: A Meta-Analysis.
Wang Y; Mambiya M; Li Q; Yang L; Jia H; Han Y; Liu W
J Stroke Cerebrovasc Dis; 2018 Aug; 27(8):2259-2270. PubMed ID: 29752070
[TBL] [Abstract][Full Text] [Related]
10. Renovascular hypertension and
Kim JY; Cho H
Clin Nephrol; 2021 Aug; 96(2):105-111. PubMed ID: 33769276
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis of genotype and phenotype studies to confirm the predictive role of the RNF213 p.R4810K variant for moyamoya disease.
Wang Y; Yang L; Wang X; Zeng F; Zhang K; Zhang Q; Liu M; Liu S; Shang M; Li Q; Yang Y; Liang M; Liu W
Eur J Neurol; 2021 Mar; 28(3):823-836. PubMed ID: 33175469
[TBL] [Abstract][Full Text] [Related]
12. Frequency of RNF213 p.R4810K, a susceptibility variant for moyamoya disease, and health characteristics of carriers in the Japanese population.
Cao Y; Kobayashi H; Morimoto T; Kabata R; Harada KH; Koizumi A
Environ Health Prev Med; 2016 Sep; 21(5):387-390. PubMed ID: 27365075
[TBL] [Abstract][Full Text] [Related]
13. Genotype-Phenotype Correlation in Long-Term Cohort of Japanese Patients with Moyamoya Disease.
Nomura S; Yamaguchi K; Akagawa H; Kawashima A; Moteki Y; Ishikawa T; Aihara Y; Saito T; Okada Y; Kawamata T
Cerebrovasc Dis; 2019; 47(3-4):105-111. PubMed ID: 30947170
[TBL] [Abstract][Full Text] [Related]
14. Neuregulin 1 as a potential biomarker for disease progression in moyamoya disease: A case-control study in Chinese population.
Chen J; Zheng H; Wu X; Niu X; Dai Y; Zhou Z; Ye F
J Stroke Cerebrovasc Dis; 2024 Mar; 33(3):107581. PubMed ID: 38224792
[TBL] [Abstract][Full Text] [Related]
15. Absence of the RNF213 p.R4810K variant may indicate a severe form of pediatric moyamoya disease in Japanese patients.
Hara S; Mukawa M; Akagawa H; Thamamongood T; Inaji M; Tanaka Y; Maehara T; Kasuya H; Nariai T
J Neurosurg Pediatr; 2022 Jan; 29(1):48-56. PubMed ID: 34624841
[TBL] [Abstract][Full Text] [Related]
16. Association of
Xue Y; Zeng C; Ge P; Liu C; Li J; Zhang Y; Zhang D; Zhang Q; Zhao J
Stroke; 2022 Sep; 53(9):2906-2916. PubMed ID: 35543128
[TBL] [Abstract][Full Text] [Related]
17. Characterization of Moyamoya and Middle Cerebral Artery Diseases by Carotid Canal Diameter and RNF213 p.R4810K Genotype.
Oichi Y; Mineharu Y; Agawa Y; Morimoto T; Funaki T; Hitomi T; Kobayashi H; Todo K; Tani S; Imamura H; Yoshida K; Kataoka H; Koizumi A; Sakai N; Miyamoto S
J Stroke Cerebrovasc Dis; 2022 Jun; 31(6):106481. PubMed ID: 35430511
[TBL] [Abstract][Full Text] [Related]
18. Homozygous c.14576G>A variant of RNF213 predicts early-onset and severe form of moyamoya disease.
Miyatake S; Miyake N; Touho H; Nishimura-Tadaki A; Kondo Y; Okada I; Tsurusaki Y; Doi H; Sakai H; Saitsu H; Shimojima K; Yamamoto T; Higurashi M; Kawahara N; Kawauchi H; Nagasaka K; Okamoto N; Mori T; Koyano S; Kuroiwa Y; Taguri M; Morita S; Matsubara Y; Kure S; Matsumoto N
Neurology; 2012 Mar; 78(11):803-10. PubMed ID: 22377813
[TBL] [Abstract][Full Text] [Related]
19. A long-term study of posterior circulation changes after revascularization in patients with moyamoya disease.
Bao XY; Tong HY; Wang QN; Wang XP; Gao G; Zhang Q; Zou ZX; Duan L
J Neurosurg; 2023 Nov; 139(5):1281-1286. PubMed ID: 37029668
[TBL] [Abstract][Full Text] [Related]
20. Validation and Extension Study Exploring the Role of RNF213 p.R4810K in 2,877 Chinese Moyamoya Disease Patients.
Wang Y; Zhang Z; Wang X; Zou Z; Ta N; Hao F; Yang Y; Li D; Liang M; Han C; Bao X; Ou L; Wang H; Yang Z; Yang R; Zeng F; Shang M; Nie F; Liu W; Duan L
J Stroke Cerebrovasc Dis; 2021 Nov; 30(11):106071. PubMed ID: 34482123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
